Monte Rosa Therapeutics, Inc.
Recent Filings
All 329 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Dunn Edmund | Principal Accounting Officer | Sale | 2,062 @ $4.45 | 23,732 | Jun 3, 2025 |
| Leo Chandra P. | — | Purchase | 10,000 @ $5.84 | 10,000 | Mar 24, 2025 |
| Nickson Philip | Chief Business & Legal Officer | Award / Grant | 36,000 | 36,000 | Jan 2, 2025 |
| Dunn Edmund | Principal Accounting Officer | Award / Grant | 11,850 | 25,794 | Jan 2, 2025 |
| Janku Filip | Chief Medical Officer | Award / Grant | 36,000 | 45,189 | Jan 2, 2025 |
| Champoux Jennifer | Chief Operating Officer | Award / Grant | 30,000 | 30,000 | Jan 2, 2025 |
| Warmuth Markus | President & CEO | Award / Grant | 128,000 | 544,538 | Jan 2, 2025 |
| Townson Sharon | Chief Scientific Officer | Award / Grant | 36,000 | 36,000 | Jan 2, 2025 |
| Versant Venture Capital VI, L.P. | — | Sale | 1,132,566 @ $6.53 | 5,099,336 | Sep 20, 2024 |
| Versant Ventures VI GP, L.P. | — | Sale | 16,047 @ $6.00 | 6,241,171 | Sep 11, 2024 |